Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID:

Biomarker discovery study of DS-8201a, an anti-HER2-antibody drug conjugate, in randomized phase III trials (DS8201-A-U301, U302, U303) in unresectable and/or metastatic breast cancer and in patients receiving DS-8201a as standard of care treatment

Status

Open

Conditions

Other

Phases

Pilot

Age Group

Adult

Main Investiagtor

Crozier, Jennifer

Practice

Breast

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Secondary Trial ID Number

PA18-1100

Keywords

Observational